0 items USD 0.00Search
Your search for "current partnering global pancreatic cancer partnering 2010 2017" gave back 48391 results.
The IDO (indoleamine 2,3-dioxygenase 1, IDO1, IDO-1, INDO, indoleamine-pyrrole 2,3-dioxygenase) inhibitors pipeline analysis report includes ongoing...
Catalog:
LPI
February 2023
Price: USD 3,660.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Pancreatic Cancer Metastasis Treatment market will...
Catalog:
Arsta
June 2022
Price: USD 3,360.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Pancreatic Cancer Metastasis Treatment market will...
Catalog:
Arsta
April 2022
Price: USD 3,360.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Pancreatic Cancer Metastasis Treatment market will...
Catalog:
Arsta
June 2022
Price: USD 3,360.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Pancreatic Cancer Therapeutics and Diagnostics market...
Catalog:
Arsta
April 2022
Price: USD 3,360.00
Monoclonal antibodies are single cell clones of antibodies, a biochemical tool that allows scientists to create antibodies that combine the...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Monoclonal antibodies are single cell clones of antibodies, a biochemical tool that allows scientists to create antibodies that combine the...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Monoclonal antibodies are single cell clones of antibodies, a biochemical tool that allows scientists to create antibodies that combine the...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The global Radiation Emergency Medications market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029...
Catalog:
GIR
November 2023
Price: USD 3,480.00
The global Anti-radiation Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR...
Catalog:
GIR
November 2023
Price: USD 3,480.00
The global B-Cell Maturation Antigen (BCMA) Targeted Therapies market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Highlights The global B-Cell Maturation Antigen (BCMA) Targeted Therapies market was valued at US$ million in 2022 and is anticipated to reach US$...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
The global B-Cell Maturation Antigen (BCMA) Targeted Therapies market was valued at US$ million in 2023 and is anticipated to reach US$ million by...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The “B-Cell Maturation Antigen (BCMA) Targeted Therapies Industry Forecast” looks at past sales and reviews total world B-Cell Maturation Antigen (...
Catalog:
LPI
March 2023
Price: USD 3,660.00
According to our Publisher latest study, the global Fibroblast Activation Protein Inhibitors market size was valued at USD million in 2022 and is...
Catalog:
GIR
February 2023
Price: USD 3,480.00
